Recommended
product-img
  • Products
  • Discover MP Targets
  • Discover Research Areas
  • mProX™ Human ABL1 Stable Cell Line

    [CAT#: S01YF-1123-KX141]
    Product Category:
    Membrane Protein Stable Cell Lines
    Subcategory:
    Kinase Cell Lines

    Datasheet MSDS Request COA

    Certificate of Analysis Lookup
    To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
    Lot Number

    Made to Order Inquiry

    Inquiry
    Host Cell Type:
    Membrane Protein Engineering:
    Fluorescent Marker:
    Resistance:
    Deliverable:

    Based on this stable cell line, we also provide cell-based in vitro assays to evaluate the effects of your compounds or antibodies.

    Sub Cat Product Name Target Protein Species Host Cell Type Assay Types Inquiry Datasheet
    S01YF-1122-KX1017 Magic™ Human ABL(ABL1) in Vitro Assay Human Kinase Assay
    S01YF-1122-KX1018 Magic™ Human ABL1[F317I] in Vitro Assay Human Kinase Assay
    S01YF-1122-KX1019 Magic™ Human ABL1[T315I] in Vitro Assay Human Kinase Assay

    Product Information

    Target Protein
    ABL1
    Target Family
    Kinases/Enzyme Drug Discovery Assays and Products
    Target Protein Species
    Human
    Host Cell Type
    K562; Jurkat; CHO-K1; HEK293
    Target Classification
    Kinase Cell Lines
    Target Research Area
    Cardiovascular Research; Reproductive Research
    Related Diseases
    Congenital Heart Defects And Skeletal Malformations Syndrome and Leukemia, Chronic Myeloid.Among its related pathways are Development Slit-Robo signaling and Cell Cycle, Mitotic.
    Gene ID
    UniProt ID

    Product Properties

    Biosafety Level
    Level 1
    Activity
    Yes
    Quantity
    10⁶ cells per vial
    Applications
    The ABL1 gene codes for a protein that is produced in cells all over the body and is involved in numerous functions. The protein ABL1 has kinase activity. In order for the ABL1 kinase to carry out its tasks, it must be turned on from its generally off state. Numerous stimuli can activate the ABL1 kinase, which can phosphate-group add a variety of proteins. Because of its diversity, ABL1 can participate in a large number of different cellular functions. Depending on the state of the cell, it can either promote controlled cell death or help cells survive. The actin cytoskeleton, a web of fibers that forms the internal framework of cells, is mediated by the ABL1 kinase through interactions with several proteins. ABL1 can also aid in controlling the activity of other genes. The customized ABL1 stable cell line can be used in antibody discovery and development, potential drug candidate screening and signaling pathway researches.

    Protocols

    Please visit our protocols page.

    Customer Reviews

    chat Charlie

    The ABL1 cell line is of high quality and performs exceptionally well in my experiments. Dec 28 2022

    chat Verified Customer

    chat Vivian

    I have purchased this ABL1 cell line and all producing reliable results. Mar 22 2023

    chat Verified Customer

    FAQ

    Any questions about our products? Please visit our frequently asked questions page.

    Published Data

    Fig.1 WASP is downregulated in CML patients and BCR-ABL1-positive cell lines.

    Western blot demonstrating WASP expression in cell lines originating from several leukemia subtypes. High amounts of WASP are expressed by BCR-ABL1-negative cell lines, whereas discrete or undetectable WASP is expressed by BCR-ABL1-positive cells. Actin served as a loading regulator.

    Ref: Pereira, Welbert O., et al. "BCR-ABL1-induced downregulation of WASP in chronic myeloid leukemia involves epigenetic modification and contributes to malignancy." Cell death & disease 8.10 (2017): e3114-e3114.

    Pubmed: 29022901

    DOI: 10.1038/cddis.2017.458

    Research Highlights

    At least one normal ABL1 allele is typically present in leukemias that express constitutively activated mutations of ABL1 tyrosine kinase (BCR-ABL1, TEL-ABL1, NUP214-ABL1).
    Dasgupta, Yashodhara, et al. "Normal ABL1 is a tumor suppressor and therapeutic target in human and mouse leukemias expressing oncogenic ABL1 kinases." Blood, The Journal of the American Society of Hematology 127.17 (2016): 2131-2143.
    Pubmed: 26864341   DOI: 10.1182/blood-2015-11-681171

    The types of tyrosine kinase-activating lesions that have been found were examined in this review, along with the preclinical and clinical data supporting the use of tyrosine kinase inhibitors in the management of this unique subtype of ALL.
    Boer, Judith M., and Monique L. den Boer. "BCR-ABL1-like acute lymphoblastic leukaemia: From bench to bedside." European Journal of Cancer 82 (2017): 203-218.
    Pubmed: 28709134   DOI: 10.1016/j.ejca.2017.06.012

    Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR CLINICAL PROCEDURES" For licensing inquiries, please contact
    Send Inquiry Send Inquiry
    Inquiry Basket
    compare

    Go to compare